In 2037 the patent will run out, and the generic price will likely be 90% less.
Fortunately, for Americans with good-enough health insurance, it's covered, so ... yay? For those without insurance, or in other countries where $300k is basically unaffordable, well bummer for you, you'll be the last generation to die of it.
I get the insane costs, and risks, of developing these things. I get that the profit motive is what drives there to be any research at all in pharma. I get that the price has to be high for everyone, or insurance companies will balk.
And yet, even knowing all that, there's a sour taste when we -could- (literally) save lives, but, well, money first ya-know...
I don't have an answer to this issue- there are downsides to all proposals I've heard. But this approach seems, well, pretty harsh.
[1] https://www.statnews.com/2023/11/03/trikafta-cystic-fibrosis....